Zinc-64 Aspartate

N/A

Report date: 2024/07/22 20:00:45

Base Information

Drug NameZinc-64 Aspartate
Drug Alias NameKLS-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraine
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVector Vitale LLC
China Registration ClassN/A

Develop Information

Active CompaniesVector Vitale LLC
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A